Hepatocellular bile salt transport: Lessons from cholestasis

Canadian Journal of Gastroenterology

Volumn 14, Issue SUPPL. D, 2000, Pages

  Trauner, Michael ^a   Fickert, Peter ^a   Stauber, Rudolf E ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Bile salts; Cholestasis; Hepatocyte; Jaundice; Mutations; Transport; Ursodeoxycholic acid

Indexed keywords

BILE ACID; CARRIER PROTEIN;

BILE; CHOLESTASIS; GENETICS; HUMAN; LIVER; LIVER CELL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SECRETION;

BILE; BILE ACIDS AND SALTS; CARRIER PROTEINS; CHOLESTASIS; HEPATOCYTES; HUMANS; LIVER;

EID: 0034328219     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/870929     Document Type: Article

References (62)

1. Boyer JL, Nathanson MH. Bile formation. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver, 8th edn. Philadelphia: Lippincott-Raven Publishers, 1999:119-46.
2. Boyer JL. Bile duct epithelium: frontiers in transport physiology. Am J Physiol 1996;270:G1-5.
3. Meier PJ, Eckhardt U, Schroeder A, Hagenbuch B, Stieger B. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 1997;26:1667-77.
4. Müller M, Jansen PLM. Molecular aspects of hepatobiliary transport. Am J Physiol 1997;272:G1285-303.
5. Müller M, Jansen PLM. The secretory function of the liver: new aspects of hepatobiliary transport. J Hepatol 1998;28:344-54.
6. +/bile acid cotransporter. J Clin Invest 1994;93:1326-31.
7. Kullak-Ublick GA, Hagenbuch B, Stieger B, et al. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 1995;109:1274-82.
8. Kullak-Ublick GA, Beuers U, Meier PJ, Domdey H, Paumgartner G. Assignment of the human organic anion transporting polypeptide (OATP) gene to chromosome 12p12 by fluorescence in situ hybridisation. J Hepatol 1996;25:985-7.
9. Kullak-Ublick GA, Beuers U, Fahney C, Hagenbuch B, Meier PJ, Paumgartner G. Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene. Hepatology 1997;26:991-7.
10. Keppler D, Arias IM. Hepatic canalicular membrane. Introduction: transport across the hepatocyte canalicular membrane. FASEB J 1997;11:15-8.
11. Ueda K, Clark DP, Chen CJ, Roninson IB, Gottesman MM, Pastan I. The human multidrug resistance (MDR1) gene. cDNA cloning and transcription initiation. J Biol Chem 1987;262:505-8.
12. van der Bliek AM, Kooiman PM, Schneider C, Borst PA. Sequence of mdr3 cDNA encoding a human P-glycoprotein. Gene 1988;71:401-11.
13. Büchler M, König J, Brom M, et al. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 1996;271:15091-8.
14. Taniguchi M, Wada M, Kohno K, et al. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 1996;56:4124-9.
15. Gerloff T, Stieger B, Hagenbuch B, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998;273:10046-50.
16. Strautnieks SS, Bull LN, Knisely AS, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998;20:233-8.
17. Martinez-Anso E, Castillo JE, Diez J, Medina JF, Prieo J. Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology 1994;19:1400-6.
18. Strazzabosco M. Transport systems in cholangiocytes: their role in bile formation and cholestasis. Yale J Biol Med 1997;70:427-34.
19. Strazzabosco M. New insights into cholangiocyte physiology. J Hepatol 1997;27:945-52.
20. +-dependent bile acid transporter in large but not small rat cholangiocytes. Gastroenterology 1997;113:1734-40.
21. Lazaridis KN, Pham L, Tietz P, et al. Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. J Clin Invest 1997;100:2714-21.
22. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998;339:1217-27.
23. Phillips MJ, Poucell S, Oda M. Biology of disease: mechanisms of cholestasis. Lab Invest 1986;54:593-608.
24. Anderson JM. Leaky junctions and cholestasis: a tight correlation. Gastroenterology 1996;110:1662-74.
25. Stieger B, Landmann L. Effects of cholestasis on membrane flow and surface polarity in hepatocytes. J Hepatol 1996;24:128-34.
26. Gartung C, Matern S. Molecular regulation of sinusoidal liver bile acid transporters during cholestasis. Yale J Biol Med 1997;70:355-63.
27. Trauner M. Molecular alterations of canalicular transport systems in experimental models of cholestasis: possible functional correlations. Yale J Biol Med 1997;70:365-78.
28. +/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology 1996;110:199-209.
29. Green RM, Beier D, Gollan JL. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 1996;111:193-8.
30. Moseley RH, Wang W, Takeda H, et al. Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis. Am J Physiol 1996;271:G137-46.
31. Simon FR, Fortune J, Iwahashi M, Gartung C, Wolkoff A, Sutherland E. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol 1997;271:G1043-52.
32. Trauner M, Gartung C, Schlosser SF, Boyer JL. Role of nitric oxide in the transcriptional regulation of bile acid transporters in endotoxin-induced cholestasis. Gastroenterology 1996;110:A1349. (Abst)
33. Trauner M, Arrese M, Lee H, Boyer JL, Karpen SJ. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest 1998;101:2092-100.
34. +-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. J Hepatol 1997;27:1051-6.
35. Vos TA, Hooiveld GJEJ, Koning H, et al. Dp-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter, mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver. Hepatology1998;28:1637-44.
36. Trauner M, Arrese M, Soroka CJ, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997;113:255-64.
37. Schrenk D, Gant TW, Preisegger KH, Silverman JA, Marino PA, Thorgeirsson SS. Induction of multidrug restance gene expression during cholestasis in rats and nonhuman primates. Hepatology 1993;17:854-60.
38. - and cholestatic rats. Hepatology 1998;28:426A. (Abst)
39. Hirohashi T, Suzuki H, Ito K, et al. Hepatic expresion of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats. Mol Pharmacol 1998;53:1068-75.
40. Shneider BL, Fox VL, Schwarz KB, et al. Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in exrahepatic biliary atresia. Hepatology 1997;25:1176-83.
41. Nozawa S, Miyazaki M, Tou HI, Nakagawa KN, Ambiru S, Shimizu H. Human MDR1 and MDR3 gene expression in the liver with obstructive jaundice. Gastroenterology 1997;112:A1349. (Abst)
42. Prieto J, Qian C, Garcia N, Diez J, Medina JF. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology 1993;105:572-8.
43. Medina JF, Martinez-Anso E, Vazquez JJ, Prieto J. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology 1997;25:12-7.
44. ++ mechanisms defective in cholestasis. J Clin Invest 1993;92:2984-93.
45. Beuers U, Throckmorton DC, Anderson MS, et al. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology 1996;110:1553-63.
46. Sela-Herman S, Bull L, Lomri N, et al. In search of a gene for hereditary cholestasis. Biochem Mol Med 1996;59:98-103.
47. Bull LN, Carlton VEH, Stricker NL, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 1997;26:155-64.
48. Carlton VEH, Knisely AS, Freimer AB. Mapping a locus for progressive familial intrahepatic cholstasis (Byler disease) to 18q21-q22, intrahepatic cholestasis region. Hum Mol Genet 1995;4:1049-53.
49. Houwen RHJ, Baharloo S, Blankenship K, et al. Genome screening by searching for shared segments: mapping a gene for benign recurrent intrahepatic cholestasis. Nat Genet 1994;8:380-6.
50. Bull LN, van Eijk MJT, Pawlikowska L, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998;18:219-24.
51. Strautnieks SS, Kagalwalla AF, Tanner MS, et al. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Am J Hum Genet 1997;61:630-3.
52. Jansen PLM, Strautnieks SS, Jacquemin E, et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Oastroenterology 1999;117:1370-9.
53. Deleuze JF, Jacuemin E, Dubuisson C, et al. Defect of multidrug resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996;23:904-8.
54. de Vree JML, Jacquemin E, Sturm E, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 1998;95:282-7.
55. Jacquemin E, Hermans D, Myara A, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 1997;25:519-23.
56. Borst P, Schinkel AH. What have we learnt thus far from mice with disrupted P-glycoprotein genes. Eur J Cancer 1996;32A:985-90.
57. Dumoulin FL, Reichel C, Sauerbruch T, Spengler U. Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction. J Hepatol 1997;26:852-6.
58. Kartenbeck J, Leuschner U, Mayer R, Keppler D. Absence of the canalicular isoform of the MRP gene encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996;23:1061-6.
59. Paulusma CC, Kool M, Bosma PJ, et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997;25:1539-42.
60. Keppler D, Kartenbeck J. The canalicular conjugate export pump encoded by the cmrp/cmoat gene. In: Boyer JL, Ockner RK, eds. Progress in Liver Disease, vol II. Philadelphia: WB Saunders Company, 1996:55-67.
61. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-4.
62. Roberts SK, Ludwig J, LaRusso NF. The pathobiology of biliary epithelia. Gastroenterology 1997;112:269-79.